EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Polyclonal and Monoclonal Antibodies for the Treatment and Prevention of Influenza

John H Beigel iD, David Oldach

The Journal of Infectious Diseases · 17.10.2025 · 232 (Supplement_3) · S347-S358

DOI: 10.1093/infdis/jiaf216 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 17.10.2025. Verfasst von John H Beigel und 1 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Allergy and Infectious Diseases, Rockville, Maryland. Hauptthemen laut MEDLINE: Influenza, Human, Antibodies, Monoclonal, Antibodies, Viral. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Institute of Allergy and Infectious Diseases, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

While at least 8 monoclonal and 3 polyclonal antibody products have been tested in clinical trials for the treatment of influenza, no products have been licensed, and most have stopped clinical development. The COVID-19 pandemic demonstrated that these approaches, especially monoclonal antibodies, may have unique potential in certain stages of disease and populations, especially in preventing severe disease in a population without preexisting immunity or in those with a limited capacity to mount an effective humoral immune response. This review summarizes past and ongoing efforts in using monoclonal and polyclonal antibodies for the treatment and prevention of influenza, focusing on products that have entered clinical trials and drawing lessons from COVID-19 to direct future efforts on these strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza, HumanAntibodies, MonoclonalAntibodies, ViralHumansCOVID-19SARS-CoV-2Clinical Trials as Topic

Stichwörter der Autor:innen

CR6261CR8020CT-P27FGI-101-1A6MEDI8852MHAA4549ATCN-032VIR-2482VIS410high titer immune globulinhigh titer immune plasma

Substanzen

Antibodies, MonoclonalAntibodies, Viral

Autor:innen und Institutionen

  • National Institute of Allergy and Infectious Diseases, Rockville, Maryland.
  • Visterra, Inc, Waltham, Massachusetts.

ORCID-Profile: John H Beigel

Förderung

  • National Institute of Allergy and Infectious Diseases
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Beigel, J. H., & Oldach, D. (2025). Polyclonal and Monoclonal Antibodies for the Treatment and Prevention of Influenza. The Journal of Infectious Diseases, 232(Supplement_3), S347-S358. https://doi.org/10.1093/infdis/jiaf216

Vancouver

Beigel JH, Oldach D. Polyclonal and Monoclonal Antibodies for the Treatment and Prevention of Influenza. The Journal of Infectious Diseases. 2025;232(Supplement_3):S347-S358. doi:10.1093/infdis/jiaf216

BibTeX
@article{Beigel2025,
  author = {Beigel, John H and Oldach, David},
  title = {Polyclonal and Monoclonal Antibodies for the Treatment and Prevention of Influenza},
  journal = {The Journal of Infectious Diseases},
  year = {2025},
  volume = {232},
  number = {Supplement_3},
  pages = {S347--S358},
  doi = {10.1093/infdis/jiaf216}
}
Kostenlos starten →